NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research

Tender summary

This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR). The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings. Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. Description of Work: The Frederick National Laboratory for Cancer Research (FNLCR), a Federally Funded Research and Development Center (FFRDC), currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute, is seeking information regarding an electronic document management system (EDMS). The EDMS is intended to control and maintain Facilities, Maintenance and Engineering (FME) Directorate construction project documentation in a central location. Leidos Biomed has requested this project to improve the document control process for FME projects. The new EDMS should enable FME to share, manage and maintain construction project documentation such as RFIs, submittals, drawings and meeting minutes in a central system. The EDMS shall allow for improved collaboration among the project team members (both internal and external) and ensure the team has access to the latest documentation. The EDMS will also allow reporting across projects for the purposes of lessons learned and tracking metrics. Leidos Biomedical Research, Inc. Point of Contact for a copy of the EDMS RFI: Cody Wenner at cody.wenner@nih.gov For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations Type: Special Notice Base Type: Special Notice Response Deadline: 2026-01-09T16:00:00-05:00 Office Address: Bethesda, MD POC: Cody Wenner, cody.wenner@nih.gov

What to check before bidding

• Located in United States.
• Source notice b8970ca2765f4b029809949de0b8c293 on SAM.gov.
• Notice published 2 Dec 2025; Tenqual indexed it 4 Dec 2025.
• Deadline listed as 9 Jan 2026.
• 2 tender documents identified.
• Create a free tender alert to catch similar opportunities before the deadline pressure starts.